Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Sell
49
ZVSA Quote, Financials, Valuation and Earnings
Last price:
$0.14
Seasonality move
:
-20.68%
Day range:
$0.14 - $0.14
52-week range:
$0.11 - $1.95
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
0.19x
Volume:
16K
Avg. volume:
35.3K
1-year change:
-88.71%
Market cap:
$1.1M
Revenue:
--
EPS (TTM):
-$5.05
Earnings Data
Next earnings date for ZVSA
Mar 26
2026
Most recent earnings per share
-$2.56
Missed by $2.56
(Nov 19/2025)
Consensus Estimate
--
(Nov 19/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ZVSA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 11/19/2025 | Q3 | -- | -- | -$2.56 | -- | -- |
| 08/13/2025 | Q2 | -- | -- | -$0.46 | -- | -- |
| 05/15/2025 | Q1 | -- | -- | -$0.73 | -- | -- |
| 12/31/2024 | Q4 | -- | -- | -$1.31 | -- | -- |
| 09/30/2024 | Q3 | -- | -- | -$2.43 | -$1.60 | -$0.83 |
| 06/30/2024 | Q2 | -- | -- | -$3.31 | -$3.75 | $0.44 |
| 03/31/2024 | Q1 | -- | -- | -$4.53 | -$3.70 | -$0.83 |
| 12/31/2023 | Q4 | -- | -- | -$32.92 | -$21.40 | -$11.52 |
| 09/30/2023 | Q3 | -- | -- | -$33.16 | -$56.00 | $22.84 |
| 06/30/2023 | Q2 | -- | -- | -$1,694.14 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | -$135.88 | -- | -- |
| 12/31/2022 | Q4 | -- | -- | -$180.25 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | -$287.36 | -- | -- |
| 06/30/2022 | Q2 | -- | -- | -$50.17 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$80.52 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$8.33 | -- | -- |
| 09/30/2021 | Q3 | -- | -- | -$40.38 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | -$45.00 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$45.97 | -- | -- |
ZyVersa Therapeutics, Inc. Earnings Questions
-
How Much did ZyVersa Therapeutics, Inc. Generate in Revenue Last Quarter?
ZyVersa Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did ZyVersa Therapeutics, Inc. Beat Earnings Last Quarter?
ZyVersa Therapeutics, Inc. announced earnings per share of -$2.56 which represents a miss of analyst forecast a -- per share.
-
Is ZyVersa Therapeutics, Inc. Profitable?
ZyVersa Therapeutics, Inc. reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for ZyVersa Therapeutics, Inc. EPS Next Year?
ZyVersa Therapeutics, Inc.'s earnings are forecast to decrease from -$8.48 per share to -$12.43 per share next year representing a decrease of -98.86%.
-
When is ZyVersa Therapeutics, Inc.'s Earnings Date?
ZyVersa Therapeutics, Inc.'s next earnings date is March 26, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
1
LW alert for Dec 20
Lamb Weston Holdings, Inc. [LW] is down 25.96% over the past day.
Buy
54
BMRN alert for Dec 20
BioMarin Pharmaceutical, Inc. [BMRN] is up 17.79% over the past day.
Buy
82
RKLB alert for Dec 20
Rocket Lab Corp. [RKLB] is up 17.72% over the past day.
